SHANGHAI, Jan. 30, 2024 /PRNewswire/ — WuXi XDC (2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of bioconjugate market; and Multitude Therapeutics, a clinical stage biotechnology company renowned for ADC…

NEW YORK, Jan. 30, 2024 /PRNewswire/ — The electric vehicle motor market is estimated to grow by USD 14.49 billion from 2023 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 20.87% during the forecast period. However, the growth momentum will progress. ABB…

NEW YORK, Jan. 30, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of GrafTech International Ltd. (NYSE: EAF) between February 8, 2019 and August 3, 2023, both dates…

– Pivotal trial found the enfortumab vedotin plus pembrolizumab combination significantly extended overall and progression-free survival vs platinum-containing chemotherapy – – If approved, PADCEV with KEYTRUDA would be the first combination in Japan to offer an alternative to…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.